Telangana Congress Claims Rapid Growth of Firms Linked to BRS Leader T. Harish Rao
The Telangana Congress has raised fresh corruption allegations against former minister and Bharat Rashtra Samithi (BRS) leader T. Harish Rao, stating that multiple commercial enterprises associated with him experienced steep revenue surges during his time holding ministerial portfolios.
What Happened
Through a statement and social media communications, the Telangana Congress alleged that T. Harish Rao created or promoted multiple commercial entities while serving in government. The party specifically highlighted Arvais Natures Products Private Limited, the marketer of Milchy Milk, pointing out that its revenue expanded by 614 percent within a single year after Rao took charge as Health Minister. According to the allegations, the company’s financial intake stood at approximately ₹7 crore prior to his tenure and climbed to ₹198 crore by the conclusion of his term.
Additionally, the Congress named Jiva Tech Surgicals Private Limited as another enterprise connected to the former minister. The ruling party noted that after facing an earlier loss of 13.9 percent, the medical equipment firm subsequently turned around to log a 54 percent rise in its business. The Congress claimed Rao leveraged his ministerial authority to secure business with hospitals and expand personal commercial interests across the decade-long tenure of the BRS administration.
Key Highlights
- Congress alleged that private companies linked to former minister T. Harish Rao grew dramatically while he was in office.
- Arvais Natures Products Private Limited reportedly saw a 614 percent revenue increase within twelve months of Rao becoming Health Minister, moving from around ₹7 crore to ₹198 crore by the end of his term.
- Jiva Tech Surgicals Private Limited, another firm cited by the Congress, transitioned from a 13.9 percent loss to a 54 percent business expansion.
- The Congress publicly questioned whether these financial gains constituted abuse of office or a quid pro quo.
- Explanations have been demanded from BRS president K. Chandrasekhar Rao and working president K.T. Rama Rao.
Why This Matters
The allegations center on accountability and ethics in governance, specifically questioning whether executive power was utilized for private financial advantage. By questioning transactions with healthcare facilities and citing revenue data from corporate entities tied to an ex-minister, the statements bring public scrutiny to the intersection between official public duties and private corporate interests under the previous government.
What to Watch Next
The Congress has formally demanded responses regarding these charges from BRS leadership, including party president K. Chandrasekhar Rao and working president K.T. Rama Rao. Any upcoming clarification, denial, or rebuttal from T. Harish Rao or the BRS leadership will determine how this political confrontation develops.
Frequently Asked Questions
Which companies were highlighted by the Congress?
The Congress specifically pointed to Arvais Natures Products Private Limited, which markets Milchy Milk, and Jiva Tech Surgicals Private Limited.
What specific revenue changes were cited?
According to the Congress, Arvais Natures Products Private Limited grew from roughly ₹7 crore before Rao took charge to ₹198 crore by his departure, recording a 614 percent rise in one year. Jiva Tech Surgicals Private Limited reportedly moved from a 13.9 percent loss to 54 percent business growth.
From whom did the Congress demand answers?
The Congress sought explanations directly from BRS president K. Chandrasekhar Rao and working president K.T. Rama Rao regarding the alleged quid pro quo and abuse of power.
Source: Based on reporting originally published by The Hindu.